Company news

Chimeric Therapeutics Limited news in 2021

Chimeric Therapeutics Limited's news releases, calls and decks from 2021, newest first.

View company

Transformative Portfolio Expansion Presentation

November 30, 2021

CLTX CAR T data shows regional control of tumour recurrence

November 21, 2021

Cltx car t presents positive initial phase 1 clinical data

November 14, 2021

First milestone on path to CDH17 car t clinical trial

October 21, 2021

European patent granted for CLTX technology used in CHM 1101

September 23, 2021

Partnership with OncoBay Clinical to advance CHM 1101

September 2, 2021

Preliminary Final Report

August 31, 2021

Chimeric Appoints Jennifer Chow as CEO & MD

August 30, 2021

IND clearance received from US FDA for CHM 1101

August 19, 2021

Chimeric licenses novel solid tumor CAR T therapy from Penn

July 27, 2021

Second Dose Cohort Initiated in CLTX CAR T Phase 1 Trial

May 23, 2021

Appendix 4C - quarterly

April 23, 2021

Successful Completion of First Patient Cohort Phase 1 Trial

April 21, 2021

Successful Completion of Dosing in First Patient Cohort

March 17, 2021

Decks in 2021